NDC 69043-038-10 - DexmedVet
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 69043-038
- Requested NDC
- 69043-038-10
- Package NDCs from labels
- 69043-038-10
- Manufacturer
- Cronus Pharma LLC
- Effective date
- 2026-04-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| DexmedVet - Cronus Pharma LLC | Cronus Pharma LLC | 2026-04-24 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69043-038-10 | DexmedVet | 10 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 10 | 4 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DEXMEDETOMIDINE HYDROCHLORIDE | DEXMEDETOMIDINE HYDROCHLORIDE | CIVICA, INC. | 1faf1ac8-ff9b-4ed9-b562-06dab971173a | 2026-10-12 | Warnings, Adverse reactions | 1018WH7F9I |
| DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE | DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE | Baxter Healthcare Company | aea9a3ad-c244-42be-9cd3-5df83fe2b522 | 2026-09-24 | Warnings, Adverse reactions | 1018WH7F9I |
| DEXMEDETOMIDINE HYDROCHLORIDE | DEXMEDETOMIDINE HYDROCHLORIDE | Baxter Healthcare Company | 32242f34-6e2b-4098-bd8e-3d55162f31b5 | 2026-09-24 | Warnings, Adverse reactions | 1018WH7F9I |
| DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE | DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE | Sandoz Inc. | 809e8f77-390f-4cc8-8c8a-4f67a249c9df | 2026-09-08 | Warnings, Adverse reactions | 1018WH7F9I |
| DEXMEDETOMIDINE HYDROCHLORIDE | DEXMEDETOMIDINE HYDROCHLORIDE | Wilshire Pharmaceuticals, Inc. | f550d2ba-49ac-4a3b-95db-692b468af479 | 2026-09-01 | Warnings, Adverse reactions | 1018WH7F9I |
| Dexmedetomidine | DEXMEDETOMIDINE | Avenacy Inc. | eee6145b-d83f-4596-92d3-733934d8a3a4 | 2026-08-05 | Warnings, Adverse reactions | 1018WH7F9I |
| DEXMEDETOMIDINE | DEXMEDETOMIDINE | Meitheal Pharmaceuticals Inc. | 8fa36783-b94d-4084-8c41-40ee64192074 | 2026-08-03 | Warnings, Adverse reactions | 1018WH7F9I |
| Dexmedetomidine Hydrochloride | DEXMEDETOMIDINE HYDROCHLORIDE | Piramal Critical Care Inc | c958aeb4-69ce-c3e2-e053-2a95a90a6d8d | 2026-07-28 | Warnings, Adverse reactions | 1018WH7F9I |
| Dexmedetomidine | DEXMEDETOMIDINE | Eugia US LLC | 8c162541-986b-4b30-866c-b2631ba2c975 | 2026-07-20 | Warnings, Adverse reactions | 1018WH7F9I |
| Dexmedetomidine | DEXMEDETOMIDINE | Piramal Critical Care Inc | c116d83f-35da-19ca-e053-2a95a90a017d | 2026-06-26 | Warnings, Adverse reactions | 1018WH7F9I |
| Precedex | DEXMEDETOMIDINE HYDROCHLORIDE | Hospira, Inc. | 92b7ddaa-e45a-4b64-a802-bb5df8771dd6 | 2026-06-17 | Warnings, Adverse reactions | 1018WH7F9I |
| Dexmedetomidine HCl | DEXMEDETOMIDINE HCL | Hikma Pharmaceuticals USA Inc. | de6f01a2-9f2d-4c68-9c02-06643704acb1 | 2026-06-16 | Warnings, Adverse reactions | 1018WH7F9I |
| Dexmedetomidine Hydrochloride | DEXMEDETOMIDINE HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | ca67b379-f8b3-4d35-bf8a-235ecd4c4211 | 2026-06-15 | Warnings, Adverse reactions | 1018WH7F9I |
| Precedex | DEXMEDETOMIDINE HYDROCHLORIDE | Hospira, Inc. | 4419162d-81d4-49bd-96de-1729440bdb74 | 2026-06-09 | Warnings, Adverse reactions | 1018WH7F9I |
| Dexmedetomidine | DEXMEDETOMIDINE | Piramal Critical Care Inc | b93a71ed-0f9e-1ff9-e053-2995a90a789d | 2026-06-03 | Warnings, Adverse reactions | 1018WH7F9I |
| Dexmedetomidine | DEXMEDETOMIDINE | WG Critical Care, LLC | 0d2710f2-ee47-4114-ab5c-8dca74cdcb8d | 2026-06-02 | Warnings, Adverse reactions | 1018WH7F9I |
| Dexmedetomidine Hydrochloride | DEXMEDETOMIDINE HYDROCHLORIDE | Baxter Healthcare Corporation | 7d057255-22a1-4b69-ad7c-7337fac8e993 | 2026-05-29 | Warnings, Adverse reactions | 1018WH7F9I |
| Dexmedetomidine Hydrochloride | DEXMEDETOMIDINE HYDROCHLORIDE | Amneal Pharmaceuticals LLC | eb1ba463-ab42-4f49-9ebe-3ad5af108326 | 2026-05-28 | Warnings, Adverse reactions | 1018WH7F9I |
| PRECEDEX | DEXMEDETOMIDINE HYDROCHLORIDE | Henry Schein, Inc. | 9eb336de-5fa5-4b46-b40b-a7ca5a0864bd | 2026-05-21 | Warnings, Adverse reactions | 1018WH7F9I |
| Dexmedetomidine Hydrochloride | DEXMEDETOMIDINE HYDROCHLORIDE | Gland Pharma Limited | f307de7e-a9ab-4734-abb7-66b4e112bc51 | 2026-05-20 | Warnings, Adverse reactions | 1018WH7F9I |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.